"NewYork-Presbyterian David H. Koch Center drives the evolution of ambulatory care by providing a one-stop, multi-specialty treatment center staffed with world-class experts in digestive diseases, cancer and more. Through this state-of-the-art facility, patients will receive integrated care — from diagnosis to treatment to aftercare — and undergo complex procedures on an outpatient basis, all in a single location."

During the past decade, New York Presbyterian David H Koch Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "New York Presbyterian David H Koch Center" #1 collaborator was "National Eye Institute (NEI)" with 2 trials as a collaborator and "Pediatric Eye Disease Investigator Group" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "New York Presbyterian David H Koch Center" are "Retinopathy of Prematurity" (2 trials). Many other conditions were trialed in "New York Presbyterian David H Koch Center" in a lesser frequency.

Most popular intervention types in "New York Presbyterian David H Koch Center" are "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (2 trials) and "Laser" (1 trials). Other intervention names were less common.

The vast majority of trials in "New York Presbyterian David H Koch Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "New York Presbyterian David H Koch Center". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in New York Presbyterian David H Koch Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in New York Presbyterian David H Koch Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".